Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | The importance of monitoring metabolites during maintenance therapy in ALL

Kjeld Schmiegelow • 28 Sep 2022
SOHO 2022
Acute Lymphoblastic Leukemia Leukemia

Kjeld Schmiegelow, MD, Rigshospitalet University Hospital, Copenhagen, Denmark, comments on the importance of maintenance therapy in adult and pediatric patients with acute lymphoblastic leukemia (ALL), discussing how monitoring metabolites during maintenance therapy can help predict relapse in those patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kjeld Schmiegelow

3:11
Key findings from the NOPHO ALL2008 experience: advances in ALL diagnosis and treatment
Kjeld Schmiegelow • 28 Sep 2022
2:15
Diagnosing & managing CNS disease in patients with ALL
Kjeld Schmiegelow • 28 Sep 2022
1:40
Mutations in ALL and their implications for treatment decisions
Kjeld Schmiegelow • 28 Sep 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals